Global 3D Bioprinting Market is expected to grow at a CAGR of 22.82% during the forecast period from 2018-2025
A new research report published by Fior Markets with the title 3D Bioprinting Market by Technology (Microextrusion, Inkjet, Laser, Magnetic), Material, Application, Regions, and Global Forecast 2018-2025.
As per the report, the global 3D bioprinting market is expected to grow from USD 834.21 Million in 2017 to USD 4,320.36 Million by 2025, at a CAGR of 22.82% during the forecast period from 2018-2025. North America region emerged as a leading market for the 3D bioprinting with a 41.63% share of revenue in 2017. Whereas Asia Pacific region is anticipated to progress at an accelerated CAGR of 24.98% over the forecast period.
DOWNLOAD FREE SAMPLE REPORT: https://www.fiormarkets.com/report-detail/386004/request-sample
Major players in the global 3D bioprinting market are Organovo Holdings Inc., EnvisionTEC GmbH, Nano3D Biosciences, Inc., Cyfuse Biomedical K.K., BioBots, Aspect Biosystems Ltd., 3Dynamic Systems Ltd., regenHU Ltd, Cellink, Regenovo Biotechnology Co., Ltd, Poietis, GeSiM, Luxexcel Group B.V., TeVido BioDevices, LLC, Stratasys Ltd, Voxeljet A.G., Materialise N.V. Solidscape, Inc., and among others. There has been flurry of activity in the 3D bioprinting research sector. For instance in 2018, Russia launched its Organ.Aut 3D bioprinter into the outer space. The zero-gravity environment in space enables the printed organs and tissues to mature at faster rates thus, making it a favorable environment compared to Earth for 3D bioprinting.
Technology segment is divided into microextrusion, inkjet, laser and magnetic 3D bioprinting. On account of being cost effective fabrication process microextrusion 3D bioprinting segment emerged as the leader in the global 3D bioprinting market with a 42.38% share of revenue in 2017. Inkjet 3D bioprinting segment is also expected to attain a significant market share owing to its compatibility with living cells. Owing to its enhanced speed and precision the magnetic 3D bioprinting segment is projected to grow at the highest CAGR of 24.78% over the forecast period. Material is segmented into extracellular matrices, hydrogels, living cells, and others. Increasing utilization of living cells in repairing the damaged tissues coupled with their compatibility with biomaterials to repair the damaged microstructures were the factors that led living cells segment to dominate the global 3D bioprinting market with a 35.71% share of revenue in 2017. Application segment is categorized into clinical application and research applications. Factors such as increased financial support from private and public entities for the 3D bioprinting research and development activities propelled research application segment to emerge as the leader with a 67.59% share of revenue in 2017. Research segment is further divided into drug research, regenerative medicine, and 3D cell culture. Clinical application segment is subdivided into skin, bone & cartilage, and blood vessels.
Factors such as growth in public and private funding for 3D bioprinting research and increasing demand for the organ transplantation are driving the global 3D bioprinting market. On the other hand stringent regulations pertaining 3D bioprinting and paucity of trained professional are anticipated to dampen the market growth.
About the report:
The global 3D Bioprinting market is analysed on the basis of value (USD Billion), volume (K Units), export (K Units), and import (K Units). All the segments have been analyzed on global, regional and country basis. The study includes an analysis of more than 30 countries for each segment. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The study includes porter’s five forces model, attractiveness analysis, raw material analysis, and competitor position grid analysis.
Customization of the Report:
The report can be customized as per client requirements. For further queries, you can contact us on email@example.com or +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.
- CDN Newswire